| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/18/2004 | EP1315504B1 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 08/18/2004 | EP1294732B1 Ruthenium (ii) compounds for use in the therapy of cancer |
| 08/18/2004 | EP1268429B1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 08/18/2004 | EP1175397B1 3,3-substituted indoline derivatives |
| 08/18/2004 | EP1087935B1 Anthracene derivatives as anti-cancer agents |
| 08/18/2004 | EP1038025A4 Genetic alterations associated with cancer |
| 08/18/2004 | EP1037636A4 Inhibition of membrane-associated viral replication |
| 08/18/2004 | EP0885006B1 Pharmaceutical composition enabling to inhibit cancer metastasis formation containing n-acetyl-cysteine and doxorubicin |
| 08/18/2004 | EP0881914B1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression |
| 08/18/2004 | EP0827544B1 Multimeric proteins |
| 08/18/2004 | EP0775160B1 Cyclic hexapeptide somatostatin analogues |
| 08/18/2004 | CN1522264A 抗cd40单克隆抗体 Monoclonal antibody anti-cd40 |
| 08/18/2004 | CN1522258A Novel 4-amino-5,6-substituted thiopheno 2,3-d]pyrimidines |
| 08/18/2004 | CN1522248A Novel butadiene derivatives, process for preparation of the same and intermediates for the synthesis thereof |
| 08/18/2004 | CN1522159A Interferon formulations |
| 08/18/2004 | CN1522156A Novel engineered superantigen for human therapy |
| 08/18/2004 | CN1522155A Method for producing a vaccine |
| 08/18/2004 | CN1522154A Vaccines including as an adjuvant type 1 IFN and process related thereto |
| 08/18/2004 | CN1522146A Use of cyclopamine in the treatment of psoriasis |
| 08/18/2004 | CN1522144A Compositions for preventing human cancer and method of preventing human cancer |
| 08/18/2004 | CN1522143A Coenzyme q and eicosapentaenoic acid (epa) |
| 08/18/2004 | CN1521258A Novel epothilones compound and its preparation method and application |
| 08/18/2004 | CN1521191A Recombinant protein molecule for inhibiting attack and transfer of cancer cell and angiogenesis |
| 08/18/2004 | CN1521188A Protein extracted from perinereis aibuhitensis, its preparation method and use |
| 08/18/2004 | CN1521182A Eucalyptus plant extract and its use |
| 08/18/2004 | CN1521171A Boric acid and boric acid ester compound ,their preparing method and use in pharmacy |
| 08/18/2004 | CN1521161A Preparation of oxaliplatin |
| 08/18/2004 | CN1520900A Injection for anti-tumor |
| 08/18/2004 | CN1520886A Application of mycoplasma-resistant pharmaceutical and P37 protein blocking agent in preparing antineoplastic medicine |
| 08/18/2004 | CN1520844A Traditional Chinese medicine composition for cancer |
| 08/18/2004 | CN1520823A Novel compound antineoplastic drug preparing process |
| 08/18/2004 | CN1520808A Carmustine precursor liposome powder injection formulation and process for preparing |
| 08/18/2004 | CN1520805A Ubiquinone containing composition |
| 08/18/2004 | CN1162541C Anemone cytotoxin gene, its coded protein and application |
| 08/18/2004 | CN1162443C Cellular injury response element and uses thereof |
| 08/18/2004 | CN1162441C Pluraflavin and derivatives thereof, process for their preparation and use thereof |
| 08/18/2004 | CN1162427C Amine derivatives compounds as medicament and its salts and esters used for medicine |
| 08/18/2004 | CN1162184C Methods and compositions for specific coagulation of vasculature |
| 08/18/2004 | CN1162181C Methods and composition for treatment of immunologically-mediated diseases using cow mycobacterium |
| 08/18/2004 | CN1162172C Traditional Chinese medicine for treating leukemia and concurrently treating aplastic anemia |
| 08/18/2004 | CN1162169C Medicine for treating cancer |
| 08/18/2004 | CN1162167C Chinese medicine for curing cancer |
| 08/18/2004 | CN1162155C Application of phenazinone derivative in preparing antineoplastic and tumor transfer-resistant medicines |
| 08/18/2004 | CN1162154C Lauryl piperazine, lauryl diethanolamine and the application of their derivatives in extracorporeal marrow purification |
| 08/18/2004 | CN1162153C Benzothiophenes series, formulations containing same, and methods |
| 08/18/2004 | CN1162150C Theopolyphenol composition for injection and its preparing process |
| 08/17/2004 | US6777577 Anticancer agents; antidiabetic agents, anticholesterol agents, cardiovascular disorders, osteoporosis |
| 08/17/2004 | US6777544 Polyamide nucleic acid derivatives and agents and processes for preparing them |
| 08/17/2004 | US6777446 Farnesoid x receptor; treating diseases associated with abnormally high or low cholesterol levels. |
| 08/17/2004 | US6777444 Nordihydroguaiaretic acid; anticancer agents, viricides |
| 08/17/2004 | US6777442 Diphenyl derivatives |
| 08/17/2004 | US6777439 Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways |
| 08/17/2004 | US6777438 Inhibitors of farnesyl protein transferase |
| 08/17/2004 | US6777434 Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 08/17/2004 | US6777427 Tetrahydroquinoline compounds |
| 08/17/2004 | US6777418 For treating or preventing emphysema, cancer and dermatological disorders |
| 08/17/2004 | US6777417 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene-2-indolinone derivatives as kinase inhibitors |
| 08/17/2004 | US6777415 Administering (1) a farnesyl protein transferase inhibitor and (2) a tyrosine kinase inhibitor. |
| 08/17/2004 | US6777409 For therapy of inflammation |
| 08/17/2004 | US6777408 Pyrido-thieno-diazepines method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 08/17/2004 | US6777402 Acidic alcoholysis of biological raw material giving crystalline alkyl pheophorbide; conversion of alkyl pheophorbide into an acidic porphyrin; reaction of the acidic porphyrin with a hydrophylic organic amine |
| 08/17/2004 | US6777386 Peptide agonist or analogue other than deslorelin; lecithin and stearin; preferably comprises a gnrh agonist and is used for the treatment of various conditions where suppression of sex hormone levels is beneficial |
| 08/17/2004 | US6777237 Bioconjugate comprises the bioactive agent and an organocobalt complex |
| 08/17/2004 | US6777200 Kinesin motor modulators derived from the marine sponge Adocia |
| 08/17/2004 | US6777194 Monoclonal antibodies against human protein Mcm3, process for their production, and their use |
| 08/17/2004 | US6776976 Bioactive agent is covalently conjugated to an organocobalt complex's cobalt atom through a non-reactive atom in the bioactive agent molecule such as peptide, protein, nucleic acid and analogues |
| 08/17/2004 | CA2212010C Extracts of shark cartilage, process of production and uses thereof |
| 08/17/2004 | CA2133177C Rapamycin formulations for oral administration |
| 08/17/2004 | CA2133175C Rapamycin formulations for oral administration |
| 08/17/2004 | CA2122908C Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |
| 08/12/2004 | WO2004067762A2 Crystallized structure of type iv collagen nc1 domain hexamer |
| 08/12/2004 | WO2004067560A2 Herpes simplex vp16 protein binding polypeptides |
| 08/12/2004 | WO2004067558A1 Means for regulating the expression of human isoforms of ant |
| 08/12/2004 | WO2004067550A2 Novel use of mifepristone and derivatives thereof as hedgehog protein signalling pathway modulators and applications of same |
| 08/12/2004 | WO2004067535A1 Thienopyrimidine compounds and use thereof |
| 08/12/2004 | WO2004067530A1 Isothiazole derivatives |
| 08/12/2004 | WO2004067526A1 CRYSTAL OF (23S)-1α-HYDROXY-27-NOR-25-METHYLENEVITAMIN D3-26,23-LACTONE AND PROCESS FOR PRODUCING THE SAME |
| 08/12/2004 | WO2004067514A1 3,3-dimethyl-8-oxoisoquinolines for medical purposes, methods for the production thereof, medicaments containing said compounds and the use of the same |
| 08/12/2004 | WO2004067498A2 Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 08/12/2004 | WO2004067480A2 Substituted phenylurea derivatives as hdac inhibitors |
| 08/12/2004 | WO2004067036A1 Devices and compositions containing boron and silicon for use in neutron capture therapy |
| 08/12/2004 | WO2004067029A1 Method of preparing a vaccine and anti-tumor vaccines |
| 08/12/2004 | WO2004067023A2 Survivin-derived peptides and use thereof |
| 08/12/2004 | WO2004067015A1 Auxiliary agent to be used in cancer therapy by dielectric heating and cancer therapy method |
| 08/12/2004 | WO2004067000A1 Benzthiazole-3 oxides useful for the treatment of proliferative disorders |
| 08/12/2004 | WO2004066994A1 Anticancer agent |
| 08/12/2004 | WO2004066959A2 Organic-arsonic compounds |
| 08/12/2004 | WO2004066947A2 Hyperthermia oncolysis co-therapy |
| 08/12/2004 | WO2004066933A2 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 08/12/2004 | WO2004066922A2 A method of treating breast cancer with androgen receptor antagonists |
| 08/12/2004 | WO2004052873A9 Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents |
| 08/12/2004 | WO2004052286A3 Tyrosine kinase inhibitors |
| 08/12/2004 | WO2004052280A3 Anti-angiogenic compounds and their use in cancer treatment |
| 08/12/2004 | WO2004048368A3 Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors |
| 08/12/2004 | WO2004046151A3 Porphyrin derivatives |
| 08/12/2004 | WO2004046118A3 2-4-(di-phenyl-amino)-pyrimidine derivatives useful for treating hyper-proliferative disorders |
| 08/12/2004 | WO2004045593A3 Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy |
| 08/12/2004 | WO2004041867A3 Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders |
| 08/12/2004 | WO2004026311A3 Use of specific inhibitors of tyrosine kinases for immunomodulation |
| 08/12/2004 | WO2004022032A3 Pharmaceutical dosage form comprising a sulfite compound |